Endocrine Abstracts

Introduction: The assessment of the glycemic regulation of patients with Type 1 Diabetes Mellitus is necessary, in order to design an individualized treatment plan, to control the complications resulting from hyper- or hypoglycemia. For this purpose, we use HbA1c, continuous glucose monitoring (CGM) with TIR (time in range), or blood glucose monitoring (BGM). However, none of the above, can be applied without the cooperation of the patient, which for various reasons, often bec...